Effect of Increased Physical Activity and Stopping Evening Snacking in Metabolic Health in Youth With Prediabetes
2 other identifiers
interventional
80
1 country
1
Brief Summary
Non-healthy eating habits and a lack of exercise contribute to prediabetes and type 2 diabetes (T2D). Evening snacking is linked to abnormal weight gain in adults and healthy adolescents. Most adolescents do not get enough exercise. This study aims to look at the benefits of more exercise and stopping evening snacking in youth with prediabetes. The study lasts 8 weeks, and participants will be randomly assigned to either an intervention group or a standard of care group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2025
CompletedStudy Start
First participant enrolled
May 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2029
May 14, 2025
May 1, 2025
4.3 years
January 7, 2025
May 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Insulin sensitivity index for glucose disposal (ISI [Gly]) during oral glucose tolerance test
Insulin sensitivity index for glycemia (ISI \[Gly\]) will be calculated with a formula using insulin and glucose area under the curves during oral glucose tolerance tests (OGTT) as described previously (Belfiore et al., Metabolism, 2001): ISI (Gly) = 2 / \[INSp x GLYp) + 1\] INSp: insulinemic area during OGTT with 3 (0, 1h and 2h) or 5 sampling (0, 30, 60, 90 and 120 min) GLYp: glycemic area during OGTT (0, 1h and 2h) or 5 sampling (0, 30, 60, 90 and 120 min) INSp and GLYp are expressed by taking the mean normal value as 1, i.e., by dividing the value observed in the person under study by the mean normal value so that, if INSp (or GLYp) is 1.5-fold the mean normal values, it will be considered as equal to 1.5, and so on. We will use appropriate "mean normal values," which will be derived from data obtained in our laboratory.
At week 9-10 following completion of 8 weeks of intervention period
Secondary Outcomes (10)
index for fat disposal (ISI [FFA]) during oral glucose tolerance test
At week 9-10 following completion of 8 weeks of intervention period
HbA1c
At week 9-10 following completion of 8 weeks of intervention period
Percentage of adiposity (percent body fat)
At week 9-10 following completion of 8 weeks of intervention period
Amino acid concentrations
At week 9-10 following completion of 8 weeks of intervention period
Adiponectin
At week 9-10 following completion of 8 weeks of intervention period
- +5 more secondary outcomes
Study Arms (2)
Intervention Arm
EXPERIMENTALParticipants in the intervention arm will be asked to perform ≥10,000 daily steps (≥5 days/week) and omit evening snacking after 8:00 p.m.
Standard of Care Arm
NO INTERVENTIONParticipants in the standard of care arm will be asked to follow recommendations of their physician.
Interventions
Participants in the intervention arm will be asked to perform ≥10,000 daily steps (≥5 days/week) and omit evening snacking after 8:00 p.m.
Eligibility Criteria
You may qualify if:
- years of age
- Having a diagnosis of prediabetes
- Engaging in frequent evening snacking
- Inadequate physical activity
You may not qualify if:
- Diagnosis of diabetes
- Significant history of chronic disease
- Evidence of significant liver or kidney disease;
- Any hormone replacement therapy; and
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Children's Hospital / Children's Nutrition Research Center / Baylor College of Medicine
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mustafa Tosur, MD
Baylor College of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 7, 2025
First Posted
January 20, 2025
Study Start
May 13, 2025
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
September 1, 2029
Last Updated
May 14, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share